OTSKY vs SNPHY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OTSKY is a Hold and SNPHY is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OTSKY’s FA Score shows that 2 FA rating(s) are green whileSNPHY’s FA Score has 0 green FA rating(s).
- OTSKY’s FA Score: 2 green, 3 red.
- SNPHY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OTSKY’s TA Score shows that 4 TA indicator(s) are bullish while SNPHY’s TA Score has 7 bullish TA indicator(s).
- OTSKY’s TA Score: 4 bullish, 5 bearish.
- SNPHY’s TA Score: 7 bullish, 2 bearish.
Price Growth
OTSKY (@Pharmaceuticals: Major) experienced а +0.67% price change this week, while SNPHY (@Pharmaceuticals: Major) price change was +5.54% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.49%. For the same industry, the average monthly price growth was -6.12%, and the average quarterly price growth was -11.03%.
Reported Earning Dates
OTSKY is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+3.49% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| OTSKY | SNPHY | OTSKY / SNPHY | |
| Capitalization | 20.6B | 3.26B | 631% |
| EBITDA | 322B | 17.2B | 1,872% |
| Gain YTD | -11.401 | -0.296 | 3,846% |
| P/E Ratio | 16.86 | 15.60 | 108% |
| Revenue | 1.81T | 270B | 669% |
| Total Cash | 506B | 62.3B | 812% |
| Total Debt | 191B | 40.1B | 476% |
OTSKY | SNPHY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 33 | 100 | |
SMR RATING 1..100 | 73 | 100 | |
PRICE GROWTH RATING 1..100 | 59 | 51 | |
P/E GROWTH RATING 1..100 | 96 | 51 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OTSKY's Valuation (29) in the null industry is somewhat better than the same rating for SNPHY (66). This means that OTSKY’s stock grew somewhat faster than SNPHY’s over the last 12 months.
OTSKY's Profit vs Risk Rating (33) in the null industry is significantly better than the same rating for SNPHY (100). This means that OTSKY’s stock grew significantly faster than SNPHY’s over the last 12 months.
OTSKY's SMR Rating (73) in the null industry is in the same range as SNPHY (100). This means that OTSKY’s stock grew similarly to SNPHY’s over the last 12 months.
SNPHY's Price Growth Rating (51) in the null industry is in the same range as OTSKY (59). This means that SNPHY’s stock grew similarly to OTSKY’s over the last 12 months.
SNPHY's P/E Growth Rating (51) in the null industry is somewhat better than the same rating for OTSKY (96). This means that SNPHY’s stock grew somewhat faster than OTSKY’s over the last 12 months.
| OTSKY | SNPHY | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 76% | N/A |
| Stochastic ODDS (%) | 3 days ago 59% | 3 days ago 62% |
| Momentum ODDS (%) | 3 days ago 61% | 3 days ago 68% |
| MACD ODDS (%) | 3 days ago 61% | 3 days ago 60% |
| TrendWeek ODDS (%) | 3 days ago 63% | 3 days ago 62% |
| TrendMonth ODDS (%) | 3 days ago 60% | 3 days ago 59% |
| Advances ODDS (%) | N/A | 3 days ago 54% |
| Declines ODDS (%) | 4 days ago 66% | 16 days ago 66% |
| BollingerBands ODDS (%) | 3 days ago 71% | 3 days ago 69% |
| Aroon ODDS (%) | 3 days ago 72% | 3 days ago 51% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NRCFX | 12.07 | 0.17 | +1.43% |
| Natixis AEW Global Focused Real Estate C | |||
| LSMNX | 12.03 | 0.06 | +0.50% |
| Loomis Sayles Small/Mid Cap Growth N | |||
| ERBCX | 16.45 | 0.07 | +0.43% |
| Eaton Vance RBA Equity Strategy Fd Cl C | |||
| VMVLX | 238.61 | 0.04 | +0.02% |
| Vanguard Mega Cap Value Index Instl | |||
| MBCNX | 13.30 | -0.04 | -0.30% |
| MassMutual Blue Chip Growth R3 | |||
OTSKY and
Correlation & Price change
A.I.dvisor indicates that over the last year, OTSKY has been loosely correlated with OPHLY. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OTSKY jumps, then OPHLY could also see price increases.
| Ticker / NAME | Correlation To OTSKY | 1D Price Change % | ||
|---|---|---|---|---|
| OTSKY | 100% | +1.35% | ||
| OPHLY - OTSKY | 41% Loosely correlated | +4.80% | ||
| DSNKY - OTSKY | 37% Loosely correlated | -0.50% | ||
| CHGCY - OTSKY | 33% Poorly correlated | +20.79% | ||
| ALPMY - OTSKY | 22% Poorly correlated | +1.52% | ||
| AMRN - OTSKY | 22% Poorly correlated | -2.67% | ||
More | ||||
SNPHY and
Correlation & Price change
A.I.dvisor tells us that SNPHY and RHHBF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and RHHBF's prices will move in lockstep.
| Ticker / NAME | Correlation To SNPHY | 1D Price Change % | ||
|---|---|---|---|---|
| SNPHY | 100% | +1.71% | ||
| RHHBF - SNPHY | 9% Poorly correlated | +6.32% | ||
| RHHVF - SNPHY | 9% Poorly correlated | +2.02% | ||
| RHHBY - SNPHY | 6% Poorly correlated | +0.83% | ||
| OTSKY - SNPHY | 3% Poorly correlated | +1.35% | ||
| SNPHF - SNPHY | 1% Poorly correlated | N/A | ||
More | ||||